Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.

http://www.wikidata.org/entity/Q34049272

about

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease Functional genomics of human brain development and implications for autism spectrum disorders Involvement of microRNA in microglia-mediated immune response Neuronal dark matter: the emerging role of microRNAs in neurodegeneration Issues and prospects of microRNA-based biomarkers in blood and other body fluids MicroRNAs as biomarkers for CNS disease A blood based 12-miRNA signature of Alzheimer disease patients Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease Neuroprotection of microRNA in neurological disorders (Review)miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias RNA metabolism in the pathogenesis of Parkinson׳s disease Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease.Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson's patients leukocytes Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.Studying the system-level involvement of microRNAs in Parkinson's disease Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood samples Neuro-Epigenetic Indications of Acute Stress Response in Humans: The Case of MicroRNA-29c The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders Key principles of miRNA involvement in human diseases PDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domain.MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome.miRNAs and their putative roles in the development and progression of Parkinson's disease.microRNA Profiles in Parkinson's Disease Prefrontal Cortex MicroRNAs in common human diseases.Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions.Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a.Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b microRNAs in nociceptive circuits as predictors of future clinical applications.Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's Disease Next-generation sequencing in understanding complex neurological disease A network view on Parkinson's disease.Identification of therapeutic targets for Parkinson's disease via bioinformatics analysis.Molecular mechanisms of peripheral nerve regeneration: emerging roles of microRNAs.

P2860

Q21129476-C495F4B4-B9E5-48A3-A0DD-149609F38FA4 Q26767264-125F7CF6-6EDC-4B15-B195-E4F831F80F9F Q26778520-76FEE5B0-AB74-43B0-B38F-73A5709C985D Q26851399-790DE70E-96B9-4AE4-A131-BF9F70EB5897 Q26859224-85336953-DC99-41A6-BC9D-478C1AA7D4C9 Q26991755-FB7E3802-9943-493F-800F-D51F16FBBD12 Q27013998-19BF1BFE-C3BB-49FA-9BE2-188CF1E822A2 Q27499741-4DDAAF8F-1B92-4567-8992-1064264C85FA Q28080047-0C49B3E6-44D3-406E-823F-787D5BF05D10 Q28550937-405C4CDC-0C5A-46F9-8725-C784F331235F Q33567669-0DAD9ACC-0F10-44FB-85AF-D37E06BF78CE Q33732095-DDD752EC-FC6D-46EA-A19F-009C301A931F Q33787858-A6AF59FA-CE13-4DDD-ACF9-7C592831000C Q33905821-CA699443-D3BA-4A9F-BE4F-4DB7A8E4CAFA Q33932509-7D254144-CE94-4574-BE01-C55D13EB8DAF Q34125869-81294D98-42C9-4E7B-A9EC-ABC14E73087B Q34175642-09A2504D-913B-4B6D-A706-5749585032A9 Q34289150-0ECDF538-68DE-458C-BA3A-EDC7E08CA5C4 Q34831484-E928A932-7CBA-4517-A7B9-7AAFF0635D0C Q35014097-94A84FE4-41E3-4920-A540-AF5E544E415B Q35137389-A963E949-C76D-4B75-872C-BFAD80BF9A98 Q35322482-299B13A6-7800-4083-B30E-4A2AF57DE1B0 Q35885239-3DB8E955-C4B7-4D9C-AEEE-C3CFDEC3EA5B Q35966911-0EBA5E0E-8C40-4FB9-B18D-E7377267AD81 Q35990222-7BB2F7EF-6E1F-46B2-B353-3C24D6D66DCA Q36086743-1993527C-110F-4910-96E6-DAA8F0779613 Q36367369-6D84DBC7-BAF8-419A-945B-0B3B009D8B25 Q36518947-06B80DAF-A07F-47C9-B446-5F8154390622 Q36634755-F6D83561-76FD-48EC-B7FC-060AD64755BE Q36727816-434E7E53-3581-4DD5-ADEB-706862EA7219 Q36838683-4E668D8B-C689-46AF-9310-820C57004B52 Q36881831-F7F74E33-C289-4F34-BC40-56D8B40ABFA7 Q37075660-7D91691E-42AF-4733-B739-16544558812F Q37218177-CA652BDA-4FBB-42A9-96C5-1108CB1D51C3 Q37233099-A60720F1-66CB-4D20-918A-5B0C08E9257D Q37314898-2274ED2A-1AE9-41E7-A1E0-F2B00818C2FC Q37331388-A2C9CD38-0CD3-4BC7-A03D-331DF4BE6CE4 Q37655091-68C000C3-037D-4361-A68D-B5547EED7267 Q37720038-8CECEB8B-13DB-4853-B42D-5439AE25EC7B Q38095915-EB4E907E-89F4-45D0-8E97-CE7E368F172D

P2860

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.

http://www.wikidata.org/entity/Q34049272

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@ast

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@en

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@nl

type

label

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@ast

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@en

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@nl

prefLabel

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@ast

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@en

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@nl

P1433

Q34049272-77584A31-4C90-4A16-A795-1B7B923F22E7

P1476

Q34049272-E926CAE7-0215-46E7-BCE6-288379C656BF

P2093

Q34049272-0C590D63-F970-470E-9111-7702E711B543

Q34049272-5FA3C133-1872-47F0-A68D-718324224989

Q34049272-825EC5DD-91DA-40A2-B7B3-289D9B6CF2D9

Q34049272-8A8EB4A3-EAB9-4609-9DEA-4D8434372748

Q34049272-A6FACD29-42E3-4BBB-A090-261C8C7DDEBD

Q34049272-AC356FED-097E-49B1-9979-35AF2B579F7E

Q34049272-B1ABA023-5851-4302-B1C5-D4A80D0ED5A6

Q34049272-C8BA58BE-DD53-4C4B-9CC6-C0C8482BE0B1

Q34049272-D6FD3A1E-8531-449D-AB75-499766C6B577

Q34049272-E8517ECC-BA15-4139-B48F-88D507193311

P2860

Q34049272-03F94513-DD1D-4FC3-90D7-5DBADDDAB884

Q34049272-07268CFA-F1FE-4F10-A5E5-BE018897E10B

Q34049272-13C0ABF4-46FA-4DFB-9F15-257BB591D735

Q34049272-14DB36D7-DDFB-4039-BC9A-6AD6B2D00388

Q34049272-159A106B-6660-41D5-88FD-11706655A990

Q34049272-1E9D7A58-602B-49A5-8A9F-BB42485FE575

Q34049272-1EA27EF5-352F-442A-9BE0-2E08D0BFC785

Q34049272-239A9B38-5F74-4E1E-AA94-404EA6F66DCB

Q34049272-25C1A35D-D229-41E0-8474-6497907B02B7

Q34049272-28C293C3-C124-4B04-85F5-A2F3EDB117AA

P304

Q34049272-EE0705D8-FC02-44C8-ADC4-66A7892C2268

P31

Q34049272-D2B56CF0-AB6C-4BCC-943F-B04C7EFFCD60

P356

Q34049272-FF89F328-56FE-4719-A7C8-DA1657E6C7E6

P407

Q34049272-AA575957-F20F-4139-9E59-8D4382F32210

P433

Q34049272-B07E85A9-BCB0-4173-BAEF-367AD11B2817

P478

Q34049272-69A5B863-9BF1-4EDC-A7BF-F7645E772FB2

P50

Q34049272-168F6DAC-BCF8-46B4-8311-1AD30F91F6E2

Q34049272-18629262-E51D-4790-A70D-1D47CCE87F0F

Q34049272-28D52951-3E0B-4FD6-8141-770C5C1EC6F3

Q34049272-5A557C8A-91EC-4E37-86CF-79411E0345F4

Q34049272-8A394B5B-4347-4451-A1BE-73FA160CFFE1

Q34049272-B0AB42DF-2965-4C9A-A082-DCE2C1EDD4ED

P577

Q34049272-58BFEB7E-39A0-4072-956A-D1A517DF2F73

P5875

Q34049272-92810839-0052-4003-AF06-5B39378AC807

P698

Q34049272-0ADBBFF4-082C-4106-B4C0-042EFE384D09

P921

Q34049272-24542BD8-8A73-4EF5-AB03-B4C541931D8F

Q34049272-25CB9987-FD82-4DB7-938D-C0F657748C31

Q34049272-540264CE-6D98-41B9-8B28-67250A4FE6C6

Q34049272-718529C5-A1D2-4144-B7A2-AFB2FBD9B80F

P932

Q34049272-18F19650-4EBD-4B02-ABDA-045DD9E4015B

P356

JOURNAL.PONE.0025443

P1433

P1476

Convergence of miRNA expressio ...... d GWAS in Parkinson's disease.

@en

P2093

Benedita V Fonseca

http://www.w3.org/2001/XMLSchema#string

Eden R Martin

http://www.w3.org/2001/XMLSchema#string

Fran Borovecki

http://www.w3.org/2001/XMLSchema#string

Kristina Gotovac

http://www.w3.org/2001/XMLSchema#string

Leonor C Guedes

http://www.w3.org/2001/XMLSchema#string

Liyong Wang

http://www.w3.org/2001/XMLSchema#string

Mário M Rosa

http://www.w3.org/2001/XMLSchema#string

Sara Violante

http://www.w3.org/2001/XMLSchema#string

Tiago F Outeiro

http://www.w3.org/2001/XMLSchema#string

Tiago Mestre

http://www.w3.org/2001/XMLSchema#string

P2860

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Molecular markers of early Parkinson's disease based on gene expression in blood

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor

Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.

High-resolution whole-genome association study of Parkinson disease.

Fast and effective prediction of microRNA/target duplexes

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

P304

e25443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0025443

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Jeffery M. Vance

Sofia A. Oliveira

Miguel M. Coelho

Joaquim Ferreira

P577

2011-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51720345

http://www.w3.org/2001/XMLSchema#string

P698

22003392

http://www.w3.org/2001/XMLSchema#string

P921

genome-wide association study

Parkinson's disease

microRNA expression

P932

3189215

http://www.w3.org/2001/XMLSchema#string